<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03734341</url>
  </required_header>
  <id_info>
    <org_study_id>2017-37</org_study_id>
    <nct_id>NCT03734341</nct_id>
  </id_info>
  <brief_title>Comparison of Two Telemonitoring Auto-titrating Modalities in OSA Patients</brief_title>
  <official_title>A Telemonitoring Crossover Study Comparing a New Incremental Fixed Pressure Titration Modality Versus Auto-adjustable Titration for CPAP-naïve Obstructive Sleep Apnea Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Basque Health Service</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Basque Health Service</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares the titration pressures achieved through two auto-titrating modalities, a
      new incremental fixed pressure mode versus routine auto-adjusting pressure mode, in
      CPAP-naïve obstructive sleep apnea patients.

      The aim of the study is to verify that this new modality achieves a lower titration pressure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In patients with obstructive sleep apnea (OSA) on CPAP treatment, a CPAP titration test is
      usually performed to achieve the optimal pressure to maintain upper airway patency, abolish
      obstructive respiratory events and reduce the occurrence of adverse events. This pressure is
      called titration pressure.

      Until now, we used to perform, after an adaptation period, a single-night outpatient test
      with an automated device preset on auto-adjusting pressure modality (APAP).

      The incremental fixed pressure modality (EZ START) was initially developed to ease patients
      into having a positive sleep therapy experience from the very beginning. This mode gradually
      increases air pressure night-by-night until the preset therapeutic pressure is reached. In
      each good therapy session, the device performs in fixed pressure overnight and we get a real
      residual apnea-hypopnea index (rAHI).

      For this study, we will use the same device (DreamStation auto CPAP, Philips Respironics,
      Murrysville, PA, USA), a web-based system to telemonitor patient therapy (EncoreAnywhere) and
      perform for each individual patient the two modalities in a telemonitoring crossover
      randomized single-blind (patient) way.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Actual">January 7, 2019</completion_date>
  <primary_completion_date type="Actual">September 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Titration pressure</measure>
    <time_frame>14-day maximum period</time_frame>
    <description>Titration pressure in any modality</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CPAP Adherence</measure>
    <time_frame>14-day period</time_frame>
    <description>Adjusted adherence: days of use (%) * hours of use (mean)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CPAP Efficacy</measure>
    <time_frame>14-day period</time_frame>
    <description>Residual AHI (mean) in the period</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Apnea</condition>
  <condition>Sleep Apnea Syndromes</condition>
  <condition>Sleep Apnea, Obstructive</condition>
  <condition>Sleep Disordered Breathing</condition>
  <condition>Respiration; Sleep Disorder</condition>
  <condition>Respiratory Tract Disease</condition>
  <condition>Sleep Disorders, Intrinsic</condition>
  <condition>Sleep Wake Disorders</condition>
  <arm_group>
    <arm_group_label>EZ START Titration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CPAP titration test performed with an auto CPAP device preset on incremental fixed pressure modality. If the titration pressure is achieved (in a 14-day maximum period) the device will be immediately and remotely preset in CPAP modality with EZ START pressure (if any) for a 14-day period to check the titration pressure performance in a short-time period.
Afterwards, the device will be remotely preset on the next modality: auto-adjusting pressure (no wash-out period).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>APAP Titration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CPAP titration test performed with an auto CPAP device preset on auto-adjusting pressure modality. If the titration pressure is achieved (in a 14-day maximum period) the device will be immediately and remotely preset in CPAP modality with APAP pressure (if any) for a 14-day period to check the titration pressure performance in a short-time period.
Afterwards, the device will be remotely preset on the next modality: incremental fixed pressure (no wash-out period).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EZ START Titration</intervention_name>
    <description>The auto CPAP device gradually increases air pressure night-by-night until the preset therapeutic pressure is reached.
Pressure range: from 5 to 14 cmH2O. Ramp: 4cmH2O, 20 minutes. Mask: nasal (if no contraindication).
Titration pressure: fixed pressure that reduces rAHI below 10, mask leak below 10% of the session, time session above 4 hours.</description>
    <arm_group_label>APAP Titration</arm_group_label>
    <arm_group_label>EZ START Titration</arm_group_label>
    <other_name>DreamStation auto CPAP</other_name>
    <other_name>Philips Respironics</other_name>
    <other_name>EncoreAnywhere</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>APAP Titration</intervention_name>
    <description>The auto CPAP device continuously adjusts the pressure in real time to the minimum pressure needed to maintain upper airway patency at any moment. Pressure range: 5 to 14 cm H2O. Ramp: 4cmH2O, 20 minutes. Mask: nasal (if no contraindication).
Titration pressure: visual analysis pressure that reduces rAHI below 10 during 90% of the session, mask leak below 10% of the session, therapeutic session above 4 hours.</description>
    <arm_group_label>APAP Titration</arm_group_label>
    <arm_group_label>EZ START Titration</arm_group_label>
    <other_name>DreamStation auto CPAP</other_name>
    <other_name>Philips Respironics</other_name>
    <other_name>EncoreAnywhere</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-80

          -  OSA diagnosis

          -  CPAP therapy indication

        Exclusion Criteria:

          -  Previous CPAP therapy

          -  Severe COPD

          -  Respiratory insufficiency

          -  Obesity-hypoventilation syndrome

          -  Cardiac failure

          -  Recent cerebrovascular disease

          -  Central apnea, Cheyne Stokes or similar

          -  Important nasal insufficiency or malformation

          -  Previous pharyngeal surgery

          -  Shift work

          -  Psychosocial disability

          -  Refusal to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mikel Azpiazu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Basque Health Service</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario Araba</name>
      <address>
        <city>Vitoria-Gasteiz</city>
        <state>Alava</state>
        <zip>01004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Kushida CA, Chediak A, Berry RB, Brown LK, Gozal D, Iber C, Parthasarathy S, Quan SF, Rowley JA; Positive Airway Pressure Titration Task Force; American Academy of Sleep Medicine. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med. 2008 Apr 15;4(2):157-71.</citation>
    <PMID>18468315</PMID>
  </reference>
  <reference>
    <citation>Masa JF, Jiménez A, Durán J, Capote F, Monasterio C, Mayos M, Terán J, Hernández L, Barbé F, Maimó A, Rubio M, Montserrat JM. Alternative methods of titrating continuous positive airway pressure: a large multicenter study. Am J Respir Crit Care Med. 2004 Dec 1;170(11):1218-24. Epub 2004 Jul 28.</citation>
    <PMID>15282204</PMID>
  </reference>
  <reference>
    <citation>McArdle N, Singh B, Murphy M, Gain KR, Maguire C, Mutch S, Hillman DR. Continuous positive airway pressure titration for obstructive sleep apnoea: automatic versus manual titration. Thorax. 2010 Jul;65(7):606-11. doi: 10.1136/thx.2009.116756.</citation>
    <PMID>20627917</PMID>
  </reference>
  <reference>
    <citation>Ahmed O, Parthasarathy S. APAP and Alternative Titration Methods. Sleep Med Clin. 2010 Sep 1;5(3):361-368.</citation>
    <PMID>20806054</PMID>
  </reference>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>November 6, 2018</study_first_submitted>
  <study_first_submitted_qc>November 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2018</study_first_posted>
  <last_update_submitted>January 7, 2019</last_update_submitted>
  <last_update_submitted_qc>January 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Basque Health Service</investigator_affiliation>
    <investigator_full_name>Mikel Azpiazu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>CPAP</keyword>
  <keyword>Titration</keyword>
  <keyword>Obstructive Sleep Apnea</keyword>
  <keyword>Telemonitoring</keyword>
  <keyword>Telemedicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
    <mesh_term>Sleep Disorders, Intrinsic</mesh_term>
    <mesh_term>Disease</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

